"The California Institute of Regenerative Medicine (CIRM) voted on 24 May to accept a new strategic planwhich shrinks or eliminates support for basic research, facilities and training, while funneling more of its funds toward clinical development."
Friday, May 25, 2012
Media coverage of yesterday's $69 million in research awards and other matters involving the California stem cell agency was nearly non-existent today.
That is not unusual, however, since the $3 billion enterprise is not within the attention span of the mainstream press and electronic outlets.
The California Stem Report could find only two stories involving yesterday's actions. One by Ron Leuty appeared in the San Francisco Business Times and was a look at the grant awards. The other appeared on Nature's website.
Unfortunately, Nature's lead was incorrect. It said,
The CIRM governing board actually put off until at least July decisions on which programs to cut and which to expand. Basic research is not likely, however, to take a major hit, for a variety of reasons.
Posted by David Jensen at 12:42 PM